Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

221.96 +5.57 (+2.57%)
Streaming Delayed Price Updated: 1:41 PM EST, Jan 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
19 20 Next >
News headline image
These Nike Analysts Are No Longer Bullish; Here Are Top 5 Downgrades For Friday ↗
 
Via Benzinga
News headline image
Demystifying Charles River: Insights From 4 Analyst Reviews ↗
 
Via Benzinga
News headline image
Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
The Analyst Verdict: Charles River In The Eyes Of 4 Experts ↗
 
Via Benzinga
News headline image
The Analyst Landscape: 7 Takes On Charles River ↗
 
Via Benzinga
News headline image
Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research Alternatives
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Evaluating Charles River: Insights From 7 Financial Analysts ↗
 
Via Benzinga
News headline image
Charles River Laboratories to Present at William Blair and Jefferies Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
CRL Stock Earnings: Charles River Beats EPS, Beats Revenue for Q1 2024 ↗
CRL stock results show that Charles River beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Charles River Laboratories Announces First-Quarter 2024 Results
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
The 7 Best Growth Stocks to Buy in May 2024 ↗
Find real bargains in this marketplace with these seven best growth stocks to buy today for your portfolio. 
Via InvestorPlace
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River to Perform Plasmid Production for Ship of Theseus
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Publishes 2023 Corporate Citizenship Report
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories to Present at Barclays Global Healthcare Conference
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
The Top 3 Healthcare Stocks to Buy in March 2024 ↗
There are still bargains to be had in the medical space. These are three top healthcare stocks to buy today. 
Via InvestorPlace
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.